IMPORTANCE Opioid prescribing and overdose are leading public health problems in North
Introduction
Increased rates of opioid prescribing and the associated negative health consequences have emerged as leading public health problems in North America, 1 particularly among young and middleaged adults. 2 By 2014, Canada and the United States had the highest per capita opioid consumption in the world, 3 and deaths related to opioid use have increased dramatically in both countries. 2, 4, 5 Importantly, opioid-related death rates are increasing most quickly among adults aged 25 to 44 years 
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in the United States. 2 Consequently, the public health burden resulting from early loss of life is substantial.
Despite this, there is little recent information on the burden of opioid-related deaths in the United States. One study measuring the burden of opioid addiction globally in 2010 found that in North America, opioid dependence was responsible for nearly 1 million disability-adjusted life-years annually. 6 This study also found that more than half of disability-adjusted life-years were attributable to years of life lost (YLL), 6 indicating the important role that early loss of life has when quantifying the burden of opioid-related harm. 
Opioid-Related Deaths
We obtained population-based estimates of all deaths related to prescribed or illicit (eg, heroin and fentanyl derivatives) opioids in the United States using the CDC WONDER database. Consistent with the CDC, 9 we defined opioid-related deaths as those with an underlying cause of death related to
poisoning (International Statistical Classification of Diseases and Related Health Problems, 10th
Revision [ICD-10] codes X40-X44, X60-64, X85, and Y10-Y14) and a multiple cause of death code related to an opioid (ICD-10 codes T40.0-T40.4 and T40.6), excluding all deaths for which the age of the deceased person was unknown.
Burden of Opioid-Related Deaths
To explore the burden of opioid-related deaths by age, we stratified patients into 7 age groups at the time of death: 0 to 14 years, 15 to 24 years, 25 to 34 years, 35 to 44 years, 45 to 54 years, 55 to 64 years, and 65 years or older. We quantified the burden of opioid-related death in 2 ways. First, we identified the proportion of all deaths in each age group that were opioid related using age-specific all-cause mortality estimates as the denominator. Second, we calculated the YLL due to opioidrelated death using methods adapted from the Global Burden of Disease study. 10 We calculated YLL using standard 5-year life expectancy tables developed by the World Health Organization and did not apply discounting or age weights to align with the organization's most recent guidance. 10 We calculated YLL for men and women by multiplying the number of deaths by the standard life expectancy and adjusting for the average age at death within each 5-year age group. The YLL were aggregated into 10-year age groups overall and stratified by sex. 
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Results
Over (Table) ; however, this varied by age and sex. In particular, when stratified by age, adults aged 25 to 34 years and those aged 35 to 44 years experienced the highest burden from opioid-related deaths (12.9 YLL per 1000 population and 9.9 YLL per 1000 population, respectively). We also found that the burden of opioid-related death was higher among men ( The proportion of deaths in each age group that involved an opioid was calculated using opioid-related death data and all-cause mortality data. Death data were obtained from the Centers for Disease Control and Prevention WONDER online database. This analysis was performed at four 5-year time intervals between 2001 and 2016.
Discussion
In this population-based study of the burden of opioid-related deaths in the United States, we found that 1 in 65 deaths was opioid related in 2016, representing an enormous toll in YLL. Indeed, in the United States, the YLL from opioid-related deaths exceed those attributable to hypertension, HIV/AIDS, and pneumonia and amount to approximately one-tenth of the YLL due to cancer.
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Furthermore, this burden is highest among adults aged 25 to 34 years; in this age group, 1 in 5 deaths in the United States is opioid related.
These findings highlight changes in the burden of opioid-related deaths over time and across demographic groups in the United States. They demonstrate the important role of opioid overdose in deaths of adolescents and young adults as well as the disproportionate burden of overdose among men. Furthermore, despite the fact that opioid-related deaths do not represent a large proportion of deaths among adults aged 55 years and older, the relative increase in recent years requires attention, as it could be indicative of an aging population with increasing prevalence of opioid use disorder. This is particularly problematic as recent estimates from the United States suggest that the prevalence of opioid misuse among adults aged 50 years and older is expected to double (from 1.2% to 2.4%) between 2004 and 2020.
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Limitations
This study uses regularly collected population-based data from death certificates of US residents over a 15-year study period to generate population-based estimates of the current and changing 
Conclusions
Premature death from opioid-related causes imposes an enormous and growing public health burden across the United States. The recent increase in the proportion of deaths attributable to opioids among adolescents and young adults and the accompanying estimates of YLL are alarming, particularly among men. Furthermore, the aging population of people with opioid use disorder requires attention, as the burden of opioid overdose among adults aged 55 to 64 years is growing at a concerning rate. These trends highlight a need for tailored programs and policies that focus on both appropriate prescribing and harm reduction in these demographics.
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